HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
93 hedge funds and large institutions have $658M invested in HilleVax in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 12 reducing their positions, and 12 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 12
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
15% more funds holding
Funds holding: 81 → 93 (+12)
3.16% more ownership
Funds ownership: 88.33% → 91.5% (+3.2%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
10% less capital invested
Capital invested by funds: $730M → $658M (-$72.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$15.3M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$11.5M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$8.86M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.61M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$5.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$34.5M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$10.2M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.17M |
| 4 |
Millennium Management
New York
|
-$2.56M |
| 5 |
Walleye Capital
New York
|
-$2.36M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$84.1K | -5,056 | Closed |
|
|
EC
102
EntryPoint Capital
New York
| – | -$79.9K | -4,802 | Closed |
|
|
MLICM
103
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$26K | -1,561 | Closed |
|
|
AWM
104
Avior Wealth Management
Omaha,
Nebraska
| – | -$66 | -4 | Closed |
|
105
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$151 | +11 | +367% |
|
HLVX Hedge Fund Activity: Q2 2024 in Review
93 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q2 2024, worth a combined $658M — down 9.9% from $730M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new HLVX positions and 12 closed out — a net gain of 13 holders — while 42 added to existing stakes and 12 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $15.3M. The largest seller was VR Adviser, exiting entirely with an estimated $34.5M sold.
- 93 institutional investors held HilleVax (HLVX) as of Q2 2024, up from 81 in Q1 2024.
- Funds reported $658M of HilleVax stock for Q2 2024, down 9.9% quarter-over-quarter.
- 25 funds opened new HilleVax positions in Q2 2024 and 12 closed out, a net change of +13 holders.
- The largest HilleVax buyer in Q2 2024 was Janus Henderson Group, an estimated $15.3M added.
- The largest HilleVax seller in Q2 2024 was VR Adviser, an estimated $34.5M sold.
Based on aggregated 13F filings for Q2 2024.